Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$48.82 - $65.05 $8.77 Million - $11.7 Million
-179,734 Reduced 89.73%
20,573 $1.19 Million
Q1 2025

May 15, 2025

SELL
$56.03 - $88.57 $3.11 Million - $4.91 Million
-55,445 Reduced 21.68%
200,307 $11.7 Million
Q4 2024

Feb 14, 2025

BUY
$67.27 - $99.45 $12.9 Million - $19.1 Million
192,352 Added 303.39%
255,752 $20.6 Million
Q3 2024

Nov 14, 2024

BUY
$56.31 - $84.99 $3.57 Million - $5.39 Million
63,400 New
63,400 $5.08 Million

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $1.32B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.